Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ERN1 | O75460 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.34 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.32 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29561529 | 1.00 | MEN1 (0.41) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL4405506 | 0.81 | MEN1 (0.38) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL4403298 | 0.80 | MEN1 (0.34) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL28757237 | 0.80 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL7636146 | 0.80 | ALDH1A1 (0.34) | ALDH1A1CA1CA2 | |
| SCHEMBL23854833 | 0.80 | CA1 (0.30) | CA1CA2 | |
| SCHEMBL9321463 | 0.79 | CYP3A4 (0.37) | ALDH1A1TSHRCYP2A6HPGD | |
| SCHEMBL4445413 | 0.79 | CYP2A6 (0.34) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL4408085 | 0.78 | LMNA (0.42) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL6533122 | 0.74 | NFE2L2 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110583573-A | Construction and evaluation method of blood deficiency mouse model | 山西大学 | 2019-12-20 | — | — | CN | claimed |
| US-12077506-B2 | Indane derivatives as hypoxia inducible factor-2(α) inhibitors | NIKANG THERAPEUTICS, INC. (US) | 2024-09-03 | — | — | US | disclosed |
| US-11952493-B2 | Moisture-curing polyurethane composition containing oxazolidine | SIKA TECHNOLOGY AG (CH) | 2024-04-09 | — | — | US | disclosed |
| CN-113272299-B | Moisture-curable polyurethane compositions comprising oxazolidines | SIKA技术股份公司 | 2023-07-07 | — | — | CN | disclosed |
| EP-3898619-B1 | MOISTURE-CURABLE POLYURETHANE COMPOSITION CONTAINING OXAZOLIDINE | SIKA TECH AG (CH) | 2023-02-08 | — | — | EP | disclosed |
| US-20220025176-A1 | MOISTURE-CURING POLYURETHANE COMPOSITION CONTAINING OXAZOLIDINE | SIKA TECHNOLOGY AG (CH) | 2022-01-27 | — | — | US | disclosed |
| CN-113272299-A | Moisture-curing polyurethane composition comprising oxazolidine | SIKA技术股份公司 | 2021-08-17 | — | — | CN | disclosed |
| EP-3765453-A1 | BICYCLIC COMPOUNDS AS INHIBITORS OF PD1/PD-L1 INTERACTION/ACTIVATION | Jubilant Prodel LLC (US) | 2021-01-20 | — | — | EP | disclosed |
| CN-112105654-A | Curable resin mixture, curable resin composition, and cured product thereof | 日本化药株式会社 | 2020-12-18 | — | — | CN | disclosed |
| WO-2020031935-A1 | CURABLE RESIN MIXTURE, CURABLE RESIN COMPOSITION, AND CURED PRODUCT | 日本化薬株式会社 | 2020-02-13 | — | — | WO | disclosed |
| EP-1632291-B1 | HETEROGENEOUS CATALYST AND PROCESS FOR PRODUCING OXIRANE COMPOUND WITH THE CATALYST | NISSAN CHEMICAL IND LTD (JP) | 2009-12-16 | — | — | EP | disclosed |
| EP-2106855-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | Nissan Chemical Industries, Ltd. (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-20090082583-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-26 | — | — | US | disclosed |
| EP-1551818-B1 | THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS | SCHERING CORP (US) | 2009-02-04 | — | — | EP | disclosed |
| US-20070093667-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1632291-A1 | HETEROGENEOUS CATALYST AND PROCESS FOR PRODUCING OXIRANE COMPOUND WITH THE CATALYST | Nissan Chemical Industries, Ltd. (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-20050282730-A1 | Thrombopoetin receptor activator and process for producing the same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-12-22 | — | — | US | disclosed |
| EP-1552828-A1 | THROMBOPOETIN RECEPTOR ACTIVATOR AND PROCESS FOR PRODUCING THE SAME | Nissan Chemical Industries, Ltd. (JP) | 2005-07-13 | — | — | EP | disclosed |
| US-4438277-A | Hydronaphthalene derivatives | SANKYO COMPANY, LIMITED (JP) | 1984-03-20 | — | — | US | disclosed |
| US-4361515-A | Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use | SANKYO COMPANY, LIMITED (JP) | 1982-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093667-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | OXGR1, OXER1, OGFOD1 | MEN1 3099/4885LMNA 4881/4885THRB 3932/4885 |
| US-12077506-B2 | Indane derivatives as hypoxia inducible factor-2(α) inhibitors | HIF1AN, HIF1A, NFE2L2 | MEN1 4498/4885LMNA 2630/4885THRB 990/4885 |
| US-20090082583-A1 | Heterogeneous catalyst and process for producing oxirane compound with the catalyst | OXGR1, OGFOD1, OGDH | MEN1 3345/4885LMNA 4878/4885THRB 4020/4885 |
| US-20050282730-A1 | Thrombopoetin receptor activator and process for producing the same | PDGFRA, PTAFR, TBXA2R | MEN1 2530/4885LMNA 4099/4885THRB 128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.